KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/82284
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kumelachew Mulu Loha, | en_US |
dc.contributor.author | Najam Akhtar Shakil, | en_US |
dc.contributor.author | J. Kumar, | en_US |
dc.contributor.author | Manish K. Singh | en_US |
dc.contributor.author | Chitra Srivastava | en_US |
dc.date.accessioned | 2024-04-22T16:17:01Z | - |
dc.date.available | 2024-04-22T16:17:01Z | - |
dc.date.issued | 2012-05-04 | - |
dc.identifier.citation | Kumelachew Mulu Loha, Najam A. Shakil, Jitendra Kumar, Manish K. Singh & Chitra Srivastava (2012): Bioefficacy evaluation of nanoformulations of β-cyfluthrin against Callosobruchus maculatus (Coleoptera: Bruchidae), Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes, 47:7, 687-691 | en_US |
dc.identifier.issn | Not Available | - |
dc.identifier.uri | http://krishi.icar.gov.in/jspui/handle/123456789/82284 | - |
dc.description | Not Available | en_US |
dc.description.abstract | In the present investigation, bioefficacy of developed β-cyfluthrin formulations, utilizing laboratory synthesized poly(ethylene glycols) based amphiphilic copolymers, were evaluated against Callosobruchus maculatus (Coleoptera: Bruchidae). The bioefficacy data indicated that the formulations developed by utilizing polymers having PEG – 1500 (3c) and PEG – 2000 (3d) as the hydrophilic segment showed greater efficacy after 14 days as evident from EC50 values (2.2 and 1.58 mg L−1 respectively). Also, release from the commercial SC formulation was faster than developed formulations as the commercial formulation had the lowest EC50 value on the first day (0.51 mg L−1). The mean EC50 of the commercial formulation against C. maculatus was quite high as compared to those of developed formulations. The results suggest that depending upon the polymer matrix used, the application rate of β-cyfluthrin can be optimized to achieve insect control at the desired level and period. The results described in this paper are promising and provide a comparison of developed formulations with the commercial one showing an earlier degradation of β-cyfluthrin in the latter and relatively prolonged activity in the former. | en_US |
dc.description.sponsorship | Not Available | en_US |
dc.language.iso | English | en_US |
dc.publisher | Taylor and Francis | en_US |
dc.relation.ispartofseries | Not Available; | - |
dc.subject | β-cyfluthrin, Callosobruchus maculatus, mortality, PEG and EC50. | en_US |
dc.title | Bio-efficacy evaluation of nanoformulations of β-Cyfluthrin against Callosobruchus maculatus (Coleoptera: Bruchidae), | en_US |
dc.title.alternative | Not Available | en_US |
dc.type | Research Paper | en_US |
dc.publication.projectcode | Not Available | en_US |
dc.publication.journalname | Journal of Environmental Science & Health, Part B, | en_US |
dc.publication.volumeno | 47(7), | en_US |
dc.publication.pagenumber | 687-691. | en_US |
dc.publication.divisionUnit | Not Available | en_US |
dc.publication.sourceUrl | http://dx.doi.org/10.1080/03601234.2012.669254 | en_US |
dc.publication.authorAffiliation | ICAR::Indian Agricultural Research Institute | en_US |
dc.ICARdataUseLicence | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf | en_US |
dc.publication.journaltype | Research Journal | en_US |
dc.publication.naasrating | 7.70 | en_US |
dc.publication.impactfactor | 1.70 | en_US |
Appears in Collections: | CS-IARI-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.